Organization Overview
Historical Acquisition Tree
Alternative names
Key: Eli Lilly (84) Acquired (9)
abemaciclib (verzenio) (2017 NDA)
acetohexamide (dymelor) (1964 NDA)
atomoxetine (strattera) (2002 NDA)
baricitinib (olumiant) (2018 NDA)
benoxaprofen (Oraflex) (NDA)
betazole (histalog) (1953 NDA)
capreomycin (capastat) (NDA)
cefaclor (ceclor) (1979 NDA)
cefalotin (NDA)
cefamandole (mandol) (1978 NDA)
cefazolin (ancef) (1985)
ceftazidime (fortaz) (1985)
cefuroxime (zinacef) (1986)
cephalexin (keflex) (1972)
cephaloglycin (kafocin) (1970 NDA)
cinoxacin (cinobac) (1980 NDA)
cyanocobalamin (berocca) (1973)
cyclothiazide (anhydron) (1963 NDA)
cycrimine (pagitane) (1953 NDA)
dextropropoxyphene (NDA)
dicoumarol (1976 NDA)
diethylstilbestrol (Fosfestrol) (NDA)
diethylstilbestrol diphosphate (stilphostrol) (1947 NDA)
digitoxin (Acylanid) (NDA)
dirithromycin (dynabac) (1995 NDA)
dobutamine (dobutrex) (1978 NDA)
drostanolone (drolban) (1961 NDA)
drotrecogin alfa, activated (xigris) (2001 NDA)
dulaglutide (trulicity) (2014 NDA)
duloxetine (Cymbalta) (2004 NDA)
ergocalciferol (drisdol) (1973)
erythromycin (ilosone) (1964 NDA)
ethinamate (valmid) (1955 NDA)
fenoprofen (nalfon) (1977)
fluoxetine (prozac) (1987 NDA)
folic acid (1947)
galcanezumab-gnlm (emgality) (2018 NDA)
gemcitabine (gemzar) (1996 NDA)
glucagon (1960 NDA)
heparin (liquaemin) (1944)
histamine (1939)
indecainide (Decabid) (NDA)
Insulin, bovine (1987)
insulin glargine (toujeo) (2015)
insulin human (humulin) (1992 NDA)
insulin lispro (humalog) (1996 NDA)
Insulin, porcine (1966)
insulin, regular, beef-pork (1966)
ixekizumab (taltz) (2016 NDA)
lasmiditan (Reyvow) (2019 NDA)
levopropoxyphene (Novrad) (1962 NDA)
loracarbef (lorabid) (1991 NDA)
methadone (methadose) (NDA)
methyltestosterone (testred) (1971)
metocurine iodide (metubine) (1951 NDA)
moxalactam (moxam) (1981 NDA)
nabilone (cesamet) (NDA)
necitumumab (portrazza) (2015 NDA)
nortriptyline (aventyl) (1964)
nph iletin i (beef-pork) (iletin i) (1923 NDA)
olanzapine (zyprexa) (1996 NDA)
olaratumab (lartruvo) (2016 NDA)
paramethasone acetate (haldrone) (1961 NDA)
pemetrexed (alimta) (NDA)
penbutolol (levatol) (NDA)
pergolide (permax) (1988 NDA)
phenoxymethylpenicillin (1967)
pinacidil (Pindac) (NDA)
prasugrel (effient) (2009 NDA)
procaine merethoxylline (1954 NDA)
progesterone (progestasert) (1974)
propylthiouracil (NDA)
protamine insulin (1979)
protamine sulfate (1969 NDA)
pyridoxine (1973)
quinidine (1950 NDA)
raloxifene (evista) (1997 NDA)
ramucirumab (cyramza) (2014 NDA)
reserpine (serpasil) (1981)
secobarbital (seconal) (NDA)
somatropin (protropin) (1986)
sulfadiazine (1941)
sulfapyridine (1939 NDA)
tadalafil (cialis) (2009 NDA)
teriparatide (2002 NDA)
testosterone (delatestryl) (2010)
tirzepatide (Mounjaro) (2022)
tobramycin (nebcin) (1975 NDA)
tubocurarine (curare) (1947)
vancomycin (Vancocin) (NDA)
vinblastine (velban) (1965 NDA)
vincristine (oncovin) (1963 NDA)
vitamin a (1973)
Key: Eli Lilly (81) Acquired (13)
abciximab (Reopro) (11 trials)
abemaciclib (verzenio) (90 trials)
acetylsalicylic acid (aspirin) (5 trials)
adalimumab (humira) (9 trials)
alendronic acid (fosamax) (3 trials)
alpha-1 antitrypsin (Prolastin) (1 trial)
ambrisentan (letairis) (1 trial)
anastrozole (arimidex) (12 trials)
aripiprazole (abilify) (7 trials)
arzoxifene hydrochloride (8 trials)
atomoxetine (strattera) (69 trials)
atorvastatin (lipitor) (12 trials)
baricitinib (olumiant) (60 trials)
betamethasone (celestone) (1 trial)
calcipotriene (dovonex) (1 trial)
carbamazepine (tegretol) (4 trials)
clozapine (clozaril) (1 trial)
demeclocycline hydrochloride (declomycin) (1 trial)
drotrecogin alfa, activated (xigris) (12 trials)
dulaglutide (trulicity) (58 trials)
duloxetine (Cymbalta) (127 trials)
empagliflozin (jardiance) (54 trials)
enoxaparin (lovenox) (5 trials)
escitalopram (lexapro) (6 trials)
etanercept (enbrel) (4 trials)
everolimus (zortress) (3 trials)
exenatide (byetta) (73 trials)
florbetapir (Amyvid) (39 trials)
fluoxetine (prozac) (16 trials)
fulvestrant (faslodex) (18 trials)
gabapentin (neurontin) (1 trial)
galcanezumab-gnlm (emgality) (26 trials)
glimepiride (amaryl) (12 trials)
guselkumab (tremfya) (1 trial)
haloperidol (haldol) (5 trials)
insulin lispro (humalog) (122 trials)
ixekizumab (taltz) (39 trials)
lamotrigine (lamictal) (1 trial)
letrozole (femara) (14 trials)
linagliptin (tradjenta) (39 trials)
liraglutide (victoza) (6 trials)
methylphenidate (ritalin) (5 trials)
olanzapine (zyprexa) (79 trials)
paclitaxel (taxol) (57 trials)
pemetrexed (alimta) (170 trials)
pioglitazone (actos) (10 trials)
pitavastatin (livalo) (2 trials)
prasugrel (effient) (27 trials)
pravastatin (pravachol) (2 trials)
pregabalin (lyrica) (4 trials)
quetiapine (seroquel) (2 trials)
raloxifene (evista) (14 trials)
rosuvastatin (crestor) (6 trials)
semaglutide (Ozempic) (3 trials)
sertraline (zoloft) (4 trials)
sibutramine (meridia) (2 trials)
sildenafil (viagra) (6 trials)
sitagliptin (januvia) (50 trials)
somatropin (protropin) (16 trials)
tadalafil (cialis) (58 trials)
testosterone (delatestryl) (8 trials)
tetracycline (tetrex) (1 trial)
ticagrelor (brilinta) (1 trial)
tirzepatide (Mounjaro) (34 trials)
topiramate (topamax) (2 trials)
valproic acid (depakene) (4 trials)
venlafaxine (effexor) (5 trials)
ziprasidone (geodon) (1 trial)
Key: Eli Lilly (69) Acquired (51)
abiraterone (zytiga) (3 trials)
acalabrutinib (calquence) (1 trial)
alteplase (Activase) (1 trial)
amantadine (symmetrel) (2 trials)
bacille calmette-guerin (1 trial)
bendamustine (treanda) (2 trials)
bevacizumab (avastin) (38 trials)
bleomycin (blenoxane) (2 trials)
bone marrow derived mesenchymal stem cells (1 trial)
cabozantinib (cometriq) (1 trial)
calcitonin salmon (Calcimar) (4 trials)
capecitabine (xeloda) (15 trials)
certolizumab pegol (cimzia) (3 trials)
cetuximab (erbitux) (68 trials)
cisplatin (platinol) (102 trials)
cyclophosphamide (cytoxan) (12 trials)
cytarabine (cytosar-u) (5 trials)
dacarbazine (dtic-dome) (3 trials)
daunorubicin (cerubidine) (1 trial)
doxorubicin (Doxil) (21 trials)
epirubicin (ellence) (4 trials)
erlotinib (tarceva) (17 trials)
estradiol (progynon depot) (2 trials)
ethinyl estradiol (Estinyl) (7 trials)
etoposide (vepesid) (8 trials)
exemestane (aromasin) (6 trials)
finasteride (Proscar) (1 trial)
fluorouracil (efudex) (30 trials)
flutemetamol F-18 (vizamyl) (1 trial)
gemcitabine (gemzar) (165 trials)
glycopyrronium (robinul) (6 trials)
hepatitis b immune globulin (human) (BayHep B) (2 trials)
ibrutinib (imbruvica) (3 trials)
icosapent ethyl (vascepa) (1 trial)
idelalisib (zydelig) (1 trial)
insulin degludec (tresiba) (14 trials)
lasmiditan (Reyvow) (29 trials)
leuprolide (lupron) (2 trials)
lithium (lithonate) (3 trials)
medroxyprogesterone (provera) (2 trials)
necitumumab (portrazza) (18 trials)
olaratumab (lartruvo) (18 trials)
olumacostat glasaretil (5 trials)
oxaliplatin (eloxatin) (27 trials)
pembrolizumab (keytruda) (21 trials)
prednisolone (hydeltra) (4 trials)
ramucirumab (cyramza) (75 trials)
reteplase (Retavase) (1 trial)
ruboxistaurin mesylate (6 trials)
sargramostim (leukine) (3 trials)
secukinumab (cosentyx) (1 trial)
streptokinase (streptase) (1 trial)
tamoxifen (nolvadex) (7 trials)
tamsulosin (flomax) (4 trials)
tenecteplase (tnkase) (1 trial)
trastuzumab (herceptin) (12 trials)
ustekinumab (stelara) (2 trials)
vandetanib (caprelsa) (1 trial)
vedolizumab (entyvio) (1 trial)
venetoclax (venclexta) (4 trials)
vinblastine (velban) (3 trials)
vinorelbine (navelbine) (10 trials)
zanubrutinib (Brukinsa) (1 trial)
Key: Eli Lilly (148) Acquired (29)
allopurinol (zyloprim) (1 trial)
atezolizumab (tecentriq) (4 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (1 trial)
azathioprine (imuran) (1 trial)
bortezomib (velcade) (3 trials)
calcitriol (rocaltrol) (1 trial)
celecoxib (celebrex) (9 trials)
cobimetinib (cotellic) (3 trials)
crizotinib (xalkori) (1 trial)
cyanocobalamin (berocca) (7 trials)
daratumumab (darzalex) (1 trial)
darolutamide (Nubeqa) (1 trial)
dasolampanel etibutil (2 trials)
degarelix acetate (firmagon) (2 trials)
diphenhydramine (benadryl) (2 trials)
encorafenib (braftovi) (1 trial)
enzalutamide (xtandi) (1 trial)
eplerenone (inspra) (2 trials)
erdafitinib (Balversa) (1 trial)
filgrastim (neupogen) (5 trials)
fludeoxyglucose f-18 (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
idarubicin (idamycin) (2 trials)
ixabepilone (ixempra) (1 trial)
larotrectinib (vitrakvi) (4 trials)
lenvatinib (lenvima) (1 trial)
levofloxacin (levaquin) (1 trial)
loperamide (imodium) (3 trials)
metoprolol (lopressor) (2 trials)
mifepristone (mifeprex) (1 trial)
mitomycin (mutamycin) (1 trial)
mitoxantrone (novantrone) (5 trials)
moxifloxacin (avelox) (8 trials)
mycophenolate (myfortic) (1 trial)
obinutuzumab (gazyva) (1 trial)
octreotide (sandostatin) (1 trial)
olaparib (lynparza) (3 trials)
omeprazole (prilosec) (9 trials)
osimertinib (tagrisso) (4 trials)
palbociclib (ibrance) (1 trial)
panitumumab (vectibix) (1 trial)
pegaspargase (oncaspar) (2 trials)